Helpline +43 (0) 512-9003-70531

p-eds.org

Sources

    Home / Sources

Sources

Many thanks to all the patients giving their agreement to publishing pictures showing the disease.

  1. Vanakker O, Callewaert B, Malfait F, Coucke P. The Genetics of Soft Connective Tissue Disorders. Annu Rev Genomics Hum Genet. 2015;16:229–55.
  2. Beighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581–94.
  3. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998 Apr 28;77(1):31–7.
  4. Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8–26.
  5. Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos Syndrome. In: Royce PM, Steinmann B, editors. Connective Tissue and Its Heritable Disorders [Internet]. John Wiley & Sons, Inc.; 2002 [cited 2017 Dec 16]. p. 431–523. Available from: http://onlinelibrary.wiley.com/doi/10.1002/0471221929.ch9/summary
  6. Beighton P, Grahame R, Bird H. Hypermobility of Joints. Berlin: Springer; 1983. doi: 10.1007/978-1-4471-3510-4
  7. McDermott ML, Holladay J, Liu D, Puklin JE, Shin DH, Cowden JW. Corneal topography in Ehlers-Danlos syndrome. J Cataract Refract Surg. 1998 Sep;24(9):1212–5.
  8. Ayres JG, Pope FM, Reidy JF, Clark TJ. Abnormalities of the lungs and thoracic cage in the Ehlers-Danlos syndrome. Thorax. 1985 Apr;40(4):300–5
  9. Giunta C, Steinmann B. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability? Am J Med Genet. 2000 Jan 3;90(1):72–9.
  10. Imamura Y, Scott IC, Greenspan DS. The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J Biol Chem. 2000 Mar 24;275(12):8749–59.
  11. Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, et al. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):70–115.
  12. Kapferer-Seebacher I, Lundberg P, Malfait F, Zschocke J. Periodontal manifestations of Ehlers-Danlos syndromes: A systematic review. J Clin Periodontol. 2017 Nov;44(11):1088–100.
  13. Kapferer-Seebacher I, Pepin M, Werner R, Aitman TJ, Nordgren A, Stoiber H, et al. Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement. Am J Hum Genet. 2016 Nov 3;99(5):1005–14.
  14. Nuss R, Manco-Johnson M. Hemostasis in Ehlers-Danlos syndrome. Patient report and literature review. Clin Pediatr (Phila). 1995 Oct;34(10):552–5.
  15. Ronceray S, Miquel J, Lucas A, Piérard GE, Hermanns-Lê T, De Paepe A, et al. Ehlers-Danlos Syndrome Type VIII: A Rare Cause of Leg Ulcers in Young Patients. Case Rep Dermatol Med. 2013;2013:469505.
  16. Budayova-Spano M, Lacroix M, Thielens NM, Arlaud GJ, Fontecilla-Camps JC, Gaboriaud C. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J. 2002 Feb 1;21(3):231–9.
  17. immune system | Description, Function, & Facts [Internet]. Encyclopedia Britannica. [cited 2017 Dec 16]. Available from: https://www.britannica.com/science/immune-system
  18. Demmer RT, Papapanou PN, Jacobs DR, Desvarieux M. Evaluating clinical periodontal measures as surrogates for bacterial exposure: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). BMC Med Res Methodol. 2010 Jan 7;10:2.
  19. Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJL, Marcenes W. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 2014 Nov;93(11):1045–53.
  20. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004;34:9–21.
  21. Albandar JM. Aggressive periodontitis: case definition and diagnostic criteria. Periodontol 2000. 2014 Jun;65(1):13–26.
  22. Pope FM, Narcisi P, Nicholls AC, Germaine D, Pals G, Richards AJ. COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol. 1996 Aug;135(2):163–81.
  23. Pope FM, Narcisi P, Nicholls AC, Liberman M, Oorthuys JW. Clinical presentations of Ehlers Danlos syndrome type IV. Arch Dis Child. 1988 Sep;63(9):1016–25.
  24. Pope FM, Nicholls AC, Narcisi P, Temple A, Chia Y, Fryer P, et al. Type III collagen mutations in Ehlers Danlos syndrome type IV and other related disorders. Clin Exp Dermatol. 1988 Sep;13(5):285–302.
  25. Clark JG, Kuhn C, Uitto J. Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies. Am Rev Respir Dis. 1980 Dec;122(6):971–8.
  26. Gelbmann CM, Köllinger M, Gmeinwieser J, Leser HG, Holstege A, Schölmerich J. Spontaneous rupture of liver in a patient with Ehlers Danlos disease type IV. Dig Dis Sci. 1997 Aug;42(8):1724–30.
  27. Sparkman RS. Ehlers-Danlos syndrome type IV: dramatic, deceptive, and deadly. Am J Surg. 1984 May;147(5):703–4.
  28. Solomon JA, Abrams L, Lichtenstein GR. GI manifestations of Ehlers-Danlos syndrome. Am J Gastroenterol. 1996 Nov;91(11):2282–8.
  29. Pearl W, Spicer M. Ehlers-Danlos syndrome. South Med J. 1981 Jan;74(1):80–1.
  30. Rudd NL, Nimrod C, Holbrook KA, Byers PH. Pregnancy complications in type IV Ehlers-Danlos Syndrome. Lancet Lond Engl. 1983 Jan 1;1(8314–5):50–3.
  31. Sykes EM. Colon perforation in Ehlers-Danlos syndrome. Report of two cases and review of the literature. Am J Surg. 1984 Mar;147(3):410–3.
  32. Pope FM, Nicholls AC. Pregnancy and Ehlers-Danlos syndrome type IV. Lancet Lond Engl. 1983 Jan 29;1(8318):249–50.
  33. Peaceman AM, Cruikshank DP. Ehlers-Danlos syndrome and pregnancy: association of type IV disease with maternal death. Obstet Gynecol. 1987 Mar;69(3 Pt 2):428–31.
  34. Nakamura Y, Hada Y, Sada I, Nagayama M. Ehlers-Danlos syndrome and pregnancy: a case of uterine rupture. Asia Oceania J Obstet Gynaecol. 1983 Sep;9(3):303–7.
  35. Gilchrist D, Schwarze U, Shields K, MacLaren L, Bridge PJ, Byers PH. Large kindred with Ehlers-Danlos syndrome type IV due to a point mutation (G571S) in the COL3A1 gene of type III procollagen: low risk of pregnancy complications and unexpected longevity in some affected relatives. Am J Med Genet. 1999 Feb 12;82(4):305–11.
  36. Beighton P. The Ehlers-Danlos Syndrome. London, William Heinemann Medical Books; 1970.
  37. Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000 Mar 9;342(10):673–80.
  38. Dowton SB, Pincott S, Demmer L. Respiratory complications of Ehlers-Danlos syndrome type IV. Clin Genet. 1996 Dec;50(6):510–4.
  39. Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, et al. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat. 2012 Oct;33(10):1485–93.
  40. Ritelli M, Dordoni C, Venturini M, Chiarelli N, Quinzani S, Traversa M, et al. Clinical and molecular characterization of 40 patients with classic Ehlers-Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. Orphanet J Rare Dis. 2013 Apr 12;8:58.
  41. Zoppi N, Chiarelli N, Cinquina V, Ritelli M, Colombi M. GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts. Hum Mol Genet. 2015 Dec 1;24(23):6769–87.
  42. Malfait F, Symoens S, De Backer J, Hermanns-Lê T, Sakalihasan N, Lapière CM, et al. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat. 2007 Apr;28(4):387–95.
  43. Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 2003 Apr;57(3):163–6.
  44. Mulvey MR, Macfarlane GJ, Beasley M, Symmons DPM, Lovell K, Keeley P, et al. Modest association of joint hypermobility with disabling and limiting musculoskeletal pain: results from a large-scale general population-based survey. Arthritis Care Res. 2013 Aug;65(8):1325–33.
  45. Tulika. Ehlers-Danlos syndrome [Internet]. [cited 2017 Dec 9]. Available from: http://www.jdrr.org/article.asp?issn=2348-2915;year=2015;volume=2;issue=1;spage=42;epage=46;aulast=Tulika
  46. Pope FM, Komorowska A, Lee KW, Speight P, Zorawska H, Ranta H, et al. Ehlers Danlos syndrome type I with novel dental features. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 1992 Oct;21(9):418–21
  47. Reference GH. Ehlers-Danlos syndrome [Internet]. Genetics Home Reference. [cited 2018 Jan 13]. Available from: https://ghr.nlm.nih.gov/condition/ehlers-danlos-syndrome
  48. Ferré FC, Frank M, Gogly B, Golmard L, Naveau A, Chérifi H, et al. Oral phenotype and scoring of vascular Ehlers-Danlos syndrome: a case-control study. BMJ Open. 2012;2(2):e000705.
  49. Gaboriaud C, Ling WL, Thielens NM, Bally I, Rossi V. Deciphering the fine details of c1 assembly and activation mechanisms: ‘mission impossible’? Front Immunol. 2014;5:565.
  50. Rossi V, Bally I, Lacroix M, Arlaud GJ, Thielens NM. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization. Methods Mol Biol Clifton NJ. 2014;1100:43–60.
  51. Patrick RA, Taubman SB, Lepow IH. Cleavage of the fourth component of human complement (C4) by activated Cls. Immunochemistry. 1970 Feb;7(2):217–25.
  52. Thielens NM, Villiers MB, Reboul A, Villiers CL, Colomb MG. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1. FEBS Lett. 1982 May 3;141(1):19–24.
  53. Amano MT, Ferriani VPL, Florido MPC, Reis ES, Delcolli MIMV, Azzolini AECS, et al. Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s gene. Mol Immunol. 2008 Mar;45(6):1693–702.

 

 

Icon attribution:

 

          Icon made by Becris from www.flaticon.com

          Icon made by Smashicons from www.flaticon.com

          Icon made by Prosymbols from www.flaticon.com